Leerink Partners Remains Bullish on Amicus Therapeutics (FOLD) Following Announced Scioderm Acquisition

Go back to Leerink Partners Remains Bullish on Amicus Therapeutics (FOLD) Following Announced Scioderm Acquisition
Amicus Therapeutics, Inc. (NASDAQ: FOLD) Delayed: 14.49 --0 (-0%)
Previous Close $14.49    52 Week High $11.78 
Open $14.49    52 Week Low $4.98 
Day High $14.49    P/E N/A 
Day Low $14.49    EPS $-1.15 
Volume 748,284